AGO2 and nasopharyngeal carcinoma: Recently, AGO2 has been demonstrated as a potential oncogene in human tumorigenesis, including head and neck squamous cell carcinoma [9], nasopharyngeal carcinoma [10], bladder cancer [11], and glioma [12].